1. Home
  2. STRO vs PGHL Comparison

STRO vs PGHL Comparison

Compare STRO & PGHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • STRO
  • PGHL
  • Stock Information
  • Founded
  • STRO 2003
  • PGHL 2018
  • Country
  • STRO United States
  • PGHL Hong Kong
  • Employees
  • STRO N/A
  • PGHL N/A
  • Industry
  • STRO Biotechnology: Biological Products (No Diagnostic Substances)
  • PGHL
  • Sector
  • STRO Health Care
  • PGHL
  • Exchange
  • STRO Nasdaq
  • PGHL NYSE
  • Market Cap
  • STRO 292.6M
  • PGHL 294.2M
  • IPO Year
  • STRO 2018
  • PGHL 2024
  • Fundamental
  • Price
  • STRO $2.84
  • PGHL $1.66
  • Analyst Decision
  • STRO Strong Buy
  • PGHL
  • Analyst Count
  • STRO 7
  • PGHL 0
  • Target Price
  • STRO $12.14
  • PGHL N/A
  • AVG Volume (30 Days)
  • STRO 1.0M
  • PGHL 6.3M
  • Earning Date
  • STRO 11-13-2024
  • PGHL 12-10-2024
  • Dividend Yield
  • STRO N/A
  • PGHL N/A
  • EPS Growth
  • STRO N/A
  • PGHL N/A
  • EPS
  • STRO N/A
  • PGHL 0.05
  • Revenue
  • STRO $160,955,000.00
  • PGHL $13,464,430.00
  • Revenue This Year
  • STRO N/A
  • PGHL N/A
  • Revenue Next Year
  • STRO N/A
  • PGHL N/A
  • P/E Ratio
  • STRO N/A
  • PGHL $27.53
  • Revenue Growth
  • STRO 230.90
  • PGHL 20.83
  • 52 Week Low
  • STRO $2.45
  • PGHL $1.31
  • 52 Week High
  • STRO $6.13
  • PGHL $107.36
  • Technical
  • Relative Strength Index (RSI)
  • STRO 41.69
  • PGHL N/A
  • Support Level
  • STRO $2.66
  • PGHL N/A
  • Resistance Level
  • STRO $2.86
  • PGHL N/A
  • Average True Range (ATR)
  • STRO 0.19
  • PGHL 0.00
  • MACD
  • STRO 0.02
  • PGHL 0.00
  • Stochastic Oscillator
  • STRO 78.00
  • PGHL 0.00

About STRO Sutro Biopharma Inc.

Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers.

About PGHL PRIMEGA GROUP HOLDINGS LIMITED

Primega Group Holdings Ltd is engaged in transportation services. It operates in the Hong Kong construction industry, mainly handling the transportation of materials excavated from construction sites. Its services principally comprise (i) soil and rock transportation services; (ii) diesel oil trading; and (iii) construction works, which mainly include ELS works and bored piling. The company provide services as a subcontractor to other construction contractors in Hong Kong. Maximum revenue is generated from soil and rock transportation services.

Share on Social Networks: